Semaglutide seems to be more effective the other GLP-1Ras.

about

Erratum to semaglutide seems to be more effective the other GLP-1Ras.

P2860

Q55020344-FDBE6466-6757-43FE-AD3A-09C176DD16A4

P2860

Semaglutide seems to be more effective the other GLP-1Ras.

Item

http://www.wikidata.org/entity/Q47114286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Semaglutide seems to be more effective the other GLP-1Ras.

@en

Semaglutide seems to be more effective the other GLP-1Ras.

@nl

type

Item

label

Semaglutide seems to be more effective the other GLP-1Ras.

@en

Semaglutide seems to be more effective the other GLP-1Ras.

@nl

prefLabel

Semaglutide seems to be more effective the other GLP-1Ras.

@en

Semaglutide seems to be more effective the other GLP-1Ras.

@nl

P1476

Semaglutide seems to be more effective the other GLP-1Ras.

@en

P2860

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes

Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.

Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists.

P304

505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/ATM.2017.11.10

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jens Juul Holst

Sten Madsbad

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29299466

http://www.w3.org/2001/XMLSchema#string

P932

5750268

http://www.w3.org/2001/XMLSchema#string

Semaglutide seems to be more effective the other GLP-1Ras.

about

P2860

P2860

Semaglutide seems to be more effective the other GLP-1Ras.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932